-
Continuing Trending of Monkeypox and Covid
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to lower risk of COVID, poor outcomes. At least 150 minutes (2.5 hours) of moderate physical activity—or 75 minutes (1.2 hours) of vigorous exercise—weekly was linked to a lower risk of…
-
Southern Hemisphere Flu Season Bodes Ill for U.S.
Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19 boosters in young kids. Data collected from two vaccine safety surveillance programs in the first 10 weeks of administration of third doses of the Pfizer/BioNTech COVID-19 to US children aged…
-
TAG Expands Assessments to Include Current Communicable Disease Data
Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health offerings to include focus on other workplace communicable diseases. Read more below. Global COVID-19 cases down 24%. The WHO’s weekly epidemiologic update showed official worldwide reports of 5.4 million new COVID-19 cases last week, down 24% from the week before,…
-
The “Why” Behind Day 6 and Multiple COVID Testing
Key Points: In today’s Recommendation for Industry, we discuss the “why” behind testing at Day 6 if you’ve been exposed and testing multiple times for COVID if you have symptoms. Read more below. CDC unveils streamlined COVID-19 guidance. As was mentioned last week, the expected guidance update was published on Thursday. Key aspects include recommendations…
-
Positive COVID Trends Enable Focus on other Emerging Disease
Key Points: In today’s Recommendation for Industry, we discuss the positive COVID trends we are seeing. Read more below. Study: Pfizer COVID vaccine efficacy wanes 27 days after dose 2 in teens. A new study finds waning Pfizer/BioNTech COVID-19 vaccine protection against symptomatic infection in Brazilian and Scottish teens starting 27 days after the second dose amid…
-
Monkeypox Takes Headlines as COVID Turns a Corner
Key Points: In today’s Recommendation for Industry, we discuss the ongoing monkeypox headlines. Read more below. US COVID cases show hints of decline. The 7-day average for new daily cases has dipped slightly to the 120,000 range over the past 3 days, according to an analysis by the Washington Post. Meanwhile, the 7-day average for new…
-
Indicators Point to CDC Reductions in COVID Control Guidelines
Key Points: In today’s Recommendation for Industry, we discuss CDC’s reduction in COVID guidelines. Read more below. New York Times reports updates about COVID: Hospitalizations continue to increase, as they have through the summer, but they remain well below the peaks reached in previous surges. Nationwide, around 43,000 people are hospitalized with the coronavirus on…
-
Is There a Risk of Monkeypox Workplace Transmission?
Key Points: In today’s Recommendation for Industry, we discuss if there is a risk of monkeypox transmission within the workplace. Read more below. Moderna announces US contract for 66 million bivalent booster doses. Moderna announced a deal worth $1.76 billion with the US government to supply an initial 66 million doses for a new COVID-19…
-
COVID becoming an endemic virus
Key Points: In today’s Recommendation for Industry, we discuss COVID becoming an endemic virus. Read more below. COVID hot spots shift; studies add evidence for Wuhan market origin. In its weekly update, the WHO said about 6.6 million new cases were reported last week, about the same as the previous week. However, cases rose in…
-
COVID Vaccines Continue to Evolve
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines. Federal officials have signaled that second boosters for those under 50 are on hold to speed production of new bivalent shots. The new bivalent booster shots will include the original…